T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity.
BACKGROUND: Synthetic peptides, representing CD4(+) T cell epitopes, derived from the primary sequence of allergen molecules have been used to down-regulate allergic inflammation in sensitised individuals. Treatment of allergic diseases with peptides may offer substantial advantages over treatment w...
Main Authors: | Adrienne Verhoef, Clare Alexander, A Barry Kay, Mark Larché |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2005-03-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC1069669?pdf=render |
Similar Items
-
T Cell Epitope Immunotherapy Induces a CD4<sup>+</sup> T Cell Population with Regulatory Activity
by: Verhoef Adrienne, et al.
Published: (2005-01-01) -
Modulation of CD4+ T cell responses by CD4+CD25+ regulatory T cells and modified T cell epitopes
by: Smith, Trevor Robert Frank
Published: (2004) -
Glutamic acid decarboxylase-derived epitopes with specific domains expand CD4(+)CD25(+) regulatory T cells.
by: Guojiang Chen, et al.
Published: (2009-09-01) -
Immunotherapy with Allergen Peptides
by: Larché Mark
Published: (2007-06-01) -
T Cell Epitope Prediction and Its Application to Immunotherapy
by: Anna-Lisa Schaap-Johansen, et al.
Published: (2021-09-01)